{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:22:26Z","timestamp":1791346946507,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00213-009-1521-8","type":"journal-article","created":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T08:12:54Z","timestamp":1238487174000},"page":"119-128","source":"Crossref","is-referenced-by-count":247,"title":["Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo"],"prefix":"10.1007","volume":"205","author":[{"given":"Atheir I.","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Hedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy B.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"1521_CR1","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1074\/jbc.R400030200","volume":"280","author":"BN Armbruster","year":"2005","unstructured":"Armbruster BN, Roth BL (2005) Mining the receptorome. J Biol Chem 280:5129\u20135132","journal-title":"J Biol Chem"},{"key":"1521_CR2","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","volume":"268","author":"JA Bard","year":"1993","unstructured":"Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 268:23422\u201323426","journal-title":"J Biol Chem"},{"key":"1521_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000026680","volume":"42","author":"N Brunello","year":"2000","unstructured":"Brunello N, Armitage R, Feinberg I, Holsboer-Trachsler E, Leger D, Linkowski P, Mendelson WB, Racagni G, Saletu B, Sharpley AL, Turek F, Van Cauter E, Mendlewicz J (2000) Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology 42:107\u2013119","journal-title":"Neuropsychobiology"},{"key":"1521_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-001-0986-x","volume":"160","author":"FP Bymaster","year":"2002","unstructured":"Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW (2002) Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl) 160:353\u2013361","journal-title":"Psychopharmacology (Berl)"},{"key":"1521_CR5","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0028-3908(87)90165-1","volume":"26","author":"L Cervo","year":"1987","unstructured":"Cervo L, Samanin R (1987) Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropharmacology 26:1469\u20131472","journal-title":"Neuropharmacology"},{"key":"1521_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","volume":"18","author":"E Dailly","year":"2004","unstructured":"Dailly E, Chenu F, Renard CE, Bourin M (2004) Dopamine, depression and antidepressants. Fundam Clin Pharmacol 18:601\u2013607","journal-title":"Fundam Clin Pharmacol"},{"key":"1521_CR7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","volume":"60","author":"JM Davis","year":"2003","unstructured":"Davis JM, Chen N, Glick ID (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60:553\u2013564","journal-title":"Arch Gen Psychiatry"},{"key":"1521_CR8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2165\/00003495-200868080-00008","volume":"68","author":"ED Deeks","year":"2008","unstructured":"Deeks ED, Keating GM (2008) Olanzapine\/fluoxetine: a review of its use in the treatment of acute bipolar depression. Drugs 68:1115\u20131137","journal-title":"Drugs"},{"key":"1521_CR9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0924-977X(00)00104-8","volume":"10","author":"F Drago","year":"2000","unstructured":"Drago F, Arezzi A, Virzi A (2000) Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats. Eur Neuropsychopharmacol 10:437\u2013442","journal-title":"Eur Neuropsychopharmacol"},{"key":"1521_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/026988119701100409","volume":"11","author":"F Ferrari","year":"1997","unstructured":"Ferrari F, Giuliani D (1997) Effects of (\u2212) eticlopride and 7-OH-DPAT on the tail-suspension test in mice. J Psychopharmacol 11:339\u2013344","journal-title":"J Psychopharmacol"},{"key":"1521_CR11","unstructured":"Gibbs A, Naudts K, Spencer E, David A (2008) Effects of amisulpride on emotional memory using a dual-process model in healthy male volunteers. J Psychopharmacol 22:1\u20139"},{"key":"1521_CR12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuropharm.2004.11.015","volume":"48","author":"M Guscott","year":"2005","unstructured":"Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton JA, Bromidge F, Owens AP, Huscroft I, Myers J, Rupniak NM, Patel S, Whiting PJ, Hutson PH, Fone KC, Biello SM, Kulagowski JJ, McAllister G (2005) Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48:492\u2013502","journal-title":"Neuropharmacology"},{"key":"1521_CR13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1073\/pnas.0337340100","volume":"100","author":"PB Hedlund","year":"2003","unstructured":"Hedlund PB, Danielson PE, Thomas EA, Slanina K, Carson MJ, Sutcliffe JG (2003) No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc Natl Acad Sci U S A 100:1375\u20131380","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1521_CR14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2005.05.012","volume":"58","author":"PB Hedlund","year":"2005","unstructured":"Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG (2005) 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry 58:831\u2013837","journal-title":"Biol Psychiatry"},{"key":"1521_CR15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","volume":"25","author":"PB Hedlund","year":"2004","unstructured":"Hedlund PB, Sutcliffe JG (2004) Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 25:481\u2013486","journal-title":"Trends Pharmacol Sci"},{"key":"1521_CR16","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1046\/j.1471-4159.1997.68041372.x","volume":"68","author":"DE Heidmann","year":"1997","unstructured":"Heidmann DE, Metcalf MA, Kohen R, Hamblin MW (1997) Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J Neurochem 68:1372\u20131381","journal-title":"J Neurochem"},{"key":"1521_CR17","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0028-3908(98)00070-7","volume":"37","author":"DE Heidmann","year":"1998","unstructured":"Heidmann DE, Szot P, Kohen R, Hamblin MW (1998) Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology 37:1621\u20131632","journal-title":"Neuropharmacology"},{"key":"1521_CR18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.npp.1301399","volume":"33","author":"KA Holick","year":"2008","unstructured":"Holick KA, Lee DC, Hen R, Dulawa SC (2008) Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33:406\u2013417","journal-title":"Neuropsychopharmacology"},{"key":"1521_CR19","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","volume":"33","author":"NH Jensen","year":"2008","unstructured":"Jensen NH, Rodriguiz RM, Caron MG, Wetsel WC, Rothman RB, Roth BL (2008) N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine\u2019s antidepressant activity. Neuropsychopharmacology 33:2303\u20132312","journal-title":"Neuropsychopharmacology"},{"key":"1521_CR20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/syn.890180404","volume":"18","author":"S Jordan","year":"1994","unstructured":"Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F (1994) In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18:294\u2013297","journal-title":"Synapse"},{"key":"1521_CR21","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.pnpbp.2007.07.005","volume":"31","author":"SW Kim","year":"2007","unstructured":"Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS (2007) Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31:1504\u20131509","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1521_CR22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2004.07.008","volume":"56","author":"M Kodama","year":"2004","unstructured":"Kodama M, Fujioka T, Duman RS (2004) Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56:570\u2013580","journal-title":"Biol Psychiatry"},{"key":"1521_CR23","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","volume":"25","author":"E Kvachnina","year":"2005","unstructured":"Kvachnina E, Liu G, Dityatev A, Renner U, Dumuis A, Richter DW, Dityateva G, Schachner M, Voyno-Yasenetskaya TA, Ponimaskin EG (2005) 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neurosci 25:7821\u20137830","journal-title":"J Neurosci"},{"key":"1521_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(96)00103-6","volume":"43","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Boyer P, Turjanski S, Rein W (1997) Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. J Affect Disord 43:95\u2013103","journal-title":"J Affect Disord"},{"key":"1521_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31\u201341","journal-title":"Lancet"},{"key":"1521_CR26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/appi.ajp.159.2.180","volume":"159","author":"S Leucht","year":"2002","unstructured":"Leucht S, Pitschel-Walz G, Engel RR, Kissling W (2002) Amisulpride, an unusual \u201catypical\u201d antipsychotic: a meta-analysis of randomized controlled trials. Am J Psychiatry 159:180\u2013190","journal-title":"Am J Psychiatry"},{"key":"1521_CR27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-6273(93)90149-L","volume":"11","author":"TW Lovenberg","year":"1993","unstructured":"Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW et al (1993) A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11:449\u2013458","journal-title":"Neuron"},{"key":"1521_CR28","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"JE Malberg","year":"2000","unstructured":"Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104\u20139110","journal-title":"J Neurosci"},{"issue":"Suppl 4","key":"1521_CR29","first-page":"S9","volume":"17","author":"SA Montgomery","year":"2002","unstructured":"Montgomery SA (2002) Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders. Int Clin Psychopharmacol 17(Suppl 4):S9\u2013S15 discussion S16\u2013S17","journal-title":"Int Clin Psychopharmacol"},{"key":"1521_CR30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hup.865","volume":"22","author":"AM Mortimer","year":"2007","unstructured":"Mortimer AM, Joyce E, Balasubramaniam K, Choudhary PC, Saleem PT (2007) Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Hum Psychopharmacol 22:445\u2013454","journal-title":"Hum Psychopharmacol"},{"key":"1521_CR31","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195171792.001.0001","volume-title":"Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting","author":"H Motulsky","year":"2004","unstructured":"Motulsky H, Christopoulos A (2004) Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting. Oxford University Press, Oxford"},{"key":"1521_CR32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0893-133X(99)00041-X","volume":"21","author":"UL Mullins","year":"1999","unstructured":"Mullins UL, Gianutsos G, Eison AS (1999) Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 21:352\u2013367","journal-title":"Neuropsychopharmacology"},{"key":"1521_CR33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1440-1681.2007.04608.x","volume":"34","author":"LS Nandam","year":"2007","unstructured":"Nandam LS, Jhaveri D, Bartlett P (2007) 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression. Clin Exp Pharmacol Physiol 34:546\u2013551","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1521_CR34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00213-002-1165-4","volume":"165","author":"GE Ott","year":"2002","unstructured":"Ott GE, Rao U, Nuccio I, Lin KM, Poland RE (2002) Effect of bupropion-SR on REM sleep: relationship to antidepressant response. Psychopharmacology (Berl) 165:29\u201336","journal-title":"Psychopharmacology (Berl)"},{"key":"1521_CR35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001040","volume":"7","author":"L Pani","year":"2002","unstructured":"Pani L, Gessa GL (2002) The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Mol Psychiatry 7:247\u2013253","journal-title":"Mol Psychiatry"},{"key":"1521_CR36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(24)36394-3","volume":"280","author":"G Perrault","year":"1997","unstructured":"Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B (1997) Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther 280:73\u201382","journal-title":"J Pharmacol Exp Ther"},{"key":"1521_CR37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000079104","volume":"50","author":"G Racagni","year":"2004","unstructured":"Racagni G, Canonico PL, Ravizza L, Pani L, Amore M (2004) Consensus on the use of substituted benzamides in psychiatric patients. Neuropsychobiology 50:134\u2013143","journal-title":"Neuropsychobiology"},{"key":"1521_CR38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","volume":"356","author":"BL Roth","year":"2007","unstructured":"Roth BL (2007) Drugs and valvular heart disease. N Engl J Med 356:6\u20139","journal-title":"N Engl J Med"},{"key":"1521_CR39","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","volume":"99","author":"BL Roth","year":"2002","unstructured":"Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 99:11934\u201311939","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1521_CR40","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","volume":"268","author":"BL Roth","year":"1994","unstructured":"Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268:1403\u20131410","journal-title":"J Pharmacol Exp Ther"},{"key":"1521_CR41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353\u2013359","journal-title":"Nat Rev Drug Discov"},{"key":"1521_CR42","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","volume":"102","author":"RB Rothman","year":"2000","unstructured":"Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL (2000) Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102:2836\u20132841","journal-title":"Circulation"},{"key":"1521_CR43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805\u2013809","journal-title":"Science"},{"key":"1521_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)36395-5","volume":"280","author":"H Schoemaker","year":"1997","unstructured":"Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997) Neurochemical characteristics of amisulpride, an atypical dopamine D2\/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280:83\u201397","journal-title":"J Pharmacol Exp Ther"},{"key":"1521_CR45","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","volume":"28","author":"DA Shapiro","year":"2003","unstructured":"Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28:1400\u20131411","journal-title":"Neuropsychopharmacology"},{"key":"1521_CR46","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","volume":"268","author":"Y Shen","year":"1993","unstructured":"Shen Y, Monsma FJ Jr, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (1993) Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268:18200\u201318204","journal-title":"J Biol Chem"},{"key":"1521_CR47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0026-895X(25)08528-1","volume":"47","author":"AJ Sleight","year":"1995","unstructured":"Sleight AJ, Carolo C, Petit N, Zwingelstein C, Bourson A (1995) Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol Pharmacol 47:99\u2013103","journal-title":"Mol Pharmacol"},{"key":"1521_CR48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0327(97)00139-0","volume":"48","author":"E Smeraldi","year":"1998","unstructured":"Smeraldi E (1998) Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study. J Affect Disord 48:47\u201356","journal-title":"J Affect Disord"},{"key":"1521_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00023210-199911010-00005","volume":"11","author":"L Staner","year":"1999","unstructured":"Staner L, Luthringer R, Macher J-P (1999) Effects of antidepressant drugs on sleep EEG in patients with major depression: mechanisms and therapeutic implications. CNS Drugs 11:49\u201360","journal-title":"CNS Drugs"},{"key":"1521_CR50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","volume":"115","author":"G Tanda","year":"1994","unstructured":"Tanda G, Carboni E, Frau R, Di Chiara G (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) 115:285\u2013288","journal-title":"Psychopharmacology (Berl)"},{"key":"1521_CR51","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.bjp.0701946","volume":"124","author":"DR Thomas","year":"1998","unstructured":"Thomas DR, Gittins SA, Collin LL, Middlemiss DN, Riley G, Hagan J, Gloger I, Ellis CE, Forbes IT, Brown AM (1998) Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br J Pharmacol 124:1300\u20131306","journal-title":"Br J Pharmacol"},{"key":"1521_CR52","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjp.0705290","volume":"139","author":"DR Thomas","year":"2003","unstructured":"Thomas DR, Melotto S, Massagrande M, Gribble AD, Jeffrey P, Stevens AJ, Deeks NJ, Eddershaw PJ, Fenwick SH, Riley G, Stean T, Scott CM, Hill MJ, Middlemiss DN, Hagan JJ, Price GW, Forbes IT (2003) SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol 139:705\u2013714","journal-title":"Br J Pharmacol"},{"key":"1521_CR53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1995.tb16327.x","volume":"115","author":"ZP To","year":"1995","unstructured":"To ZP, Bonhaus DW, Eglen RM, Jakeman LB (1995) Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br J Pharmacol 115:107\u2013116","journal-title":"Br J Pharmacol"},{"key":"1521_CR54","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","volume":"51","author":"A Wesolowska","year":"2006","unstructured":"Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E (2006) Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51:578\u2013586","journal-title":"Neuropharmacology"},{"key":"1521_CR55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s002130050614","volume":"137","author":"H Wetzel","year":"1998","unstructured":"Wetzel H, Grunder G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schroder J, Rein W, Benkert O (1998) Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology\u2014a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-\/D2-like antagonist. The Amisulpride Study Group. Psychopharmacology (Berl) 137:223\u2013232","journal-title":"Psychopharmacology (Berl)"},{"key":"1521_CR56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hipo.20184","volume":"16","author":"H Xu","year":"2006","unstructured":"Xu H, Chen Z, He J, Haimanot S, Li X, Dyck L, Li XM (2006) Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16:551\u2013559","journal-title":"Hippocampus"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1521-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-009-1521-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1521-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T19:41:21Z","timestamp":1739043681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-009-1521-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s00213-009-1521-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}